Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome

American Journal of Physiology - Endocrinology and Metabolism

Volumn 286, Issue 4 49-4, 2004, Pages

  Van Dam, Eveline W C M ^a,b   Roelfsema, Ferdinand ^a   Veldhuis, Johannes D ^c   Hogendoorn, Simone ^a   Westenberg, Jos ^a   Helmerhorst, Frans M ^a   Frölich, Marijke ^a   Krans, H Michiel J ^a   Meinders, A Edo ^a   Pijl, Hanno ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAYO CLINIC   (United States)

Author keywords

Body fat distribution; Fertility; Gonadotropins; Ovarian cycle; Sex hormones

Indexed keywords

ESTRADIOL; GONADOTROPIN; INSULIN; LUTEINIZING HORMONE; PROGESTERONE; SEX HORMONE; TESTOSTERONE;

ADULT; ARTICLE; BODY FAT; BODY WEIGHT; CALORIC RESTRICTION; CLINICAL ARTICLE; FEMALE; HUMAN; INSULIN BLOOD LEVEL; LOW CALORY DIET; LUTEINIZING HORMONE RELEASE; NEGATIVE FEEDBACK; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OVARY FOLLICLE MATURATION; OVARY POLYCYSTIC DISEASE; OVULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; VAGINA BLEEDING; WEIGHT REDUCTION;

ADULT; ANTHROPOMETRY; BIOLOGICAL MARKERS; BODY COMPOSITION; CALORIC RESTRICTION; ESTRADIOL; FEEDBACK; FEMALE; FOLLOW-UP STUDIES; GONADAL STEROID HORMONES; HUMANS; LUTEINIZING HORMONE; MENSTRUATION; OBESITY; OVULATION; POLYCYSTIC OVARY SYNDROME; PREDICTIVE VALUE OF TESTS; WEIGHT LOSS;

EID: 12144291148     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00377.2003     Document Type: Article

References (42)

1. Arroyo A, Laughlin GA, Morales AJ, and Yen SS. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab 82: 3728-3733, 1997.
2. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, and Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85: 2434-2438, 2000.
3. Carey DG, Jenkins AB, Campbell LV, Freund J, and Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45: 633-638, 1996.
4. Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, and Norman RJ. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 10: 2705-2712, 1995.
5. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, and Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84: 4006-4011, 1999.
6. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18: 774-800, 1997.
7. Dunaif A, Scott D, Finegood D, Quintana B, and Whitcomb R. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 81: 3299-3306, 1996.
8. Dunaif A and Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 52: 401-419, 2001.
9. Eagleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS, and Marshall JC. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 85: 4047-4052, 2000.
10. Evans WS, Sollenberger MJ, Booth RA Jr, Rogol AD, Urban RJ, Carlsen EC, Johnson ML, and Veldhuis JD. Contemporary aspects of discrete peak-detection algorithms. II. The paradigm of the luteinizing hormone pulse signal in women. Endocr Rev 13: 81-104, 1992.
11. Gambineri A, Pelusi C, Vicennati V, Pagotto U, and Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26: 883-896, 2002.
12. Gill S, Taylor AE, Martin KA, Welt CK, Adams JM, and Hall JE. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. J Clin Endocrinol Metab 86: 2428-2436, 2001.
13. Guzick DS, Wing R, Smith D, Berga SL, and Winters SJ. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril 61: 598-604, 1994.
14. Heard MJ, Pierce A, Carson SA, and Buster JE. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome. Fertil Steril 77: 669-673, 2002.
15. Hillier SG. Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol 179: 39-46, 2001.
16. Holte J, Bergh T, Berne C, Wide L, and Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 80: 2586-2593, 1995.
17. Homburg R. Adverse effects of luteinizing hormone on fertility: fact or fantasy. Baillieres Clin Obstet Gynaecol 12: 555-563, 1998.
18. Hotchkiss J and Knobil E. The menstrual cycle and its neuroendocrine control. In: The Physiology of Reproduction, edited by Knobil E and Neill JD. New York: Raven, 1994, p. 711-749.
19. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, and Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83: 3078-3082, 1998.
20. Langendonk JG, Pijl H, Toornvliet AC, Burggraaf K, Frolich M, Schoemaker RC, Doornbos J, Cohen AF, and Meinders AE. Circadian rhythm of plasma leptin levels in upper and lower body obese women: influence of body fat distribution and weight loss. J Clin Endocrinol Metab 83: 1706-1712, 1998.
21. Legro RS. Polycystic ovary syndrome. Phenotype to genotype. Endocrinol Metab Clin North Am 28: 379-396, 1999.
22. Marshall JC, Eagleson CA, and McCartney CR. Hypothalamic dysfunction. Mol Cell Endocrinol 183: 29-32, 2001.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, and Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
24. Nestler JE, Barlascini CO, Matt DW, Steingold KA, Plymate SR, Clore JN, and Blackard WG. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 68: 1027-1032, 1989.
25. Nestler JE and Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335: 617-623, 1996.
26. Nestler JE, Jakubowicz DJ, Evans WS, and Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338: 1876-1880, 1998.
27. Nestler JE, Stovall D, Akhter N, Iuorno MJ, and Jakubowicz DJ. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 77: 209-215, 2002.
28. Pasquali R, Antenucci D, Casimirri F, Venturoli S, Paradisi R, Fabbri R, Balestra V, Melchionda N, and Barbara L. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 68: 173-179, 1989.
29. Pastor CL, Griffin-Korf ML, Aloi JA, Evans WS, and Marshall JC. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 83: 582-590, 1998.
30. Pettersson KS and Soderholm JR. Ultrasensitive two-site immunometric assay of human lutropin by time-resolved fluorometry. Clin Chem 36: 1928-1933, 1990.
31. Polson DW, Kiddy DS, Mason HD, and Franks S. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders. Fertil Steril 51: 30-34, 1989.
32. Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev 12: 3-13, 1991.
33. Ropelato MG, Garcia-Rudaz MC, Castro-Fernandez C, Ulloa-Aguirre A, Escobar ME, Barontini M, and Veldhuis JD. A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome. J Clin Endocrinol Metab 84: 4629-4636, 1999.
34. Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, and Hall JE. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 82: 2248-2256, 1997.
35. Van Dam EW, Roelfsema F, Veldhuis JD, Helmerhorst FM, Frolich M, Meinders AE, Krans HM, and Pijl H. Increase in daily LH secretion in response to short-term calorie restriction in obese women with PCOS. Am J Physiol Endocrinol Metab 282: E865-E872, 2002.
36. Veldhuis JD, Carlson ML, and Johnson ML. The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc Natl Acad Sci USA 84: 7686-7690, 1987.
37. Veldhuis JD and Johnson M. Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol Endocrinol Metab 250: E486-E493, 1986.
38. Veldhuis JD, Zhagips and Garmey JC. Troglitazone, an insulin-sensitizing thiazolidinedione, represses combined stimulation by LH and insulin of de novo androgen biosynthesis by thecal cells in vitro. J Clin Endocrinol Metab 87: 1129-1133, 2002.
39. Voss AK and Fortune JE. Levels of messenger ribonucleic acid for cytochrome P450 17 alpha-hydroxylase and P450 aromatase in preovulatory bovine follicles decrease after the luteinizing hormone surge. Endocrinology 132: 2239-2245, 1993.
40. Willis DS, Watson H, Mason HD, Galea R, Brincat M, and Franks S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab 83: 3984-3991, 1998.
41. Zawdaki J and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Current Issues in Endocrinology and Metabolism. Polycystic Ovary Syndrome, edited by Dunaif A, Given JR, Haseltine F, and Merriam GR. Boston: Blackwell Science, 1992, p. 377-384.
42. Zhang G, Garmey JC, and Veldhuis JD. Interactive stimulation by luteinizing hormone and insulin of the steroidogenic acute regulatory (STAR) protein and 17alpha-hydroxylase/17,20-lyase (CYP17) genes in porcine theca cells. Endocrinology 141: 2735-2742, 2000.